Instil Bio (TIL) Operating Expenses (2020 - 2026)
Instil Bio (TIL) posted quarterly Operating Expenses of $7.0 million for Q1 2026, down 77.06% year-over-year from $30.6 million in Q1 2025, and down 26.65% quarter-over-quarter from $9.6 million in Q4 2025.
Instil Bio (TIL) Operating Expenses (2020 - 2026) Analysis & Trends
Instil Bio's Operating Expenses history runs 7 years deep, the most recent figure standing at $7.0 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 77.06% year-over-year to $7.0 million; the TTM figure through Mar 2026 stood at $55.0 million (down 31.34% YoY), while the FY2025 annual figure was $78.6 million, up 6.85% from the prior year.
- Operating Expenses for Q1 2026 stood at $7.0 million, down from $9.6 million in the prior quarter.
- The five-year high for Operating Expenses was $66.7 million in Q3 2023, with the low at $7.0 million in Q1 2026.
- The 5-year median for Operating Expenses is $23.6 million (2024), against an average of $32.0 million.
- The sharpest annual moves came in 2022 and 2023: Operating Expenses surged 131.96% in 2022, then plunged 77.08% in 2023.
- Instil Bio's Operating Expenses stood at $56.8 million in 2022, then plunged by 77.08% to $13.0 million in 2023, then dropped by 9.22% to $11.8 million in 2024, then declined by 19.14% to $9.6 million in 2025, then declined by 26.65% to $7.0 million in 2026.
- Business Quant data shows TIL's Operating Expenses at $7.0 million in Q1 2026, $9.6 million in Q4 2025, and $15.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Instil Bio | 50.29 Mn | 50.29 Mn | - | 5.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.58 Mn |
| Mar 31, 2026 | 7.01 Mn |
| Dec 31, 2025 | 9.56 Mn |
| Sep 30, 2025 | 15.02 Mn |
| Jun 30, 2025 | 23.44 Mn |
| Mar 31, 2025 | 30.56 Mn |
| Dec 31, 2024 | 11.82 Mn |
| Sep 30, 2024 | 23.63 Mn |
| Jun 30, 2024 | 14.14 Mn |
| Mar 31, 2024 | 23.96 Mn |
| Dec 31, 2023 | 13.02 Mn |
| Sep 30, 2023 | 66.72 Mn |
| Jun 30, 2023 | 20.99 Mn |
| Mar 31, 2023 | 58.45 Mn |
| Dec 31, 2022 | 56.80 Mn |
| Sep 30, 2022 | 56.65 Mn |
| Jun 30, 2022 | 58.72 Mn |
| Mar 31, 2022 | 54.29 Mn |
| Dec 31, 2021 | 53.75 Mn |
| Sep 30, 2021 | 43.02 Mn |